These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23913940)

  • 1. The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer.
    Jung SK; Kim JE; Lee SY; Lee MH; Byun S; Kim YA; Lim TG; Reddy K; Huang Z; Bode AM; Lee HJ; Lee KW; Dong Z
    Carcinogenesis; 2014 Jan; 35(1):123-30. PubMed ID: 23913940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K.
    Kim JE; Lee DE; Lee KW; Son JE; Seo SK; Li J; Jung SK; Heo YS; Mottamal M; Bode AM; Dong Z; Lee HJ
    Cancer Prev Res (Phila); 2011 Apr; 4(4):582-91. PubMed ID: 21330379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of the natural JNK1 inhibitor quercetagetin.
    Baek S; Kang NJ; Popowicz GM; Arciniega M; Jung SK; Byun S; Song NR; Heo YS; Kim BY; Lee HJ; Holak TA; Augustin M; Bode AM; Huber R; Dong Z; Lee KW
    J Mol Biol; 2013 Jan; 425(2):411-23. PubMed ID: 23142567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acacetin Inhibits the Growth of STAT3-Activated DU145 Prostate Cancer Cells by Directly Binding to Signal Transducer and Activator of Transcription 3 (STAT3).
    Yun S; Lee YJ; Choi J; Kim ND; Han DC; Kwon BM
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.
    Liu K; Park C; Chen H; Hwang J; Thimmegowda NR; Bae EY; Lee KW; Kim HG; Liu H; Soung NK; Peng C; Jang JH; Kim KE; Ahn JS; Bode AM; Dong Z; Kim BY; Dong Z
    Mol Carcinog; 2015 Sep; 54(9):751-60. PubMed ID: 24700667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
    Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
    Bonaccorsi L; Marchiani S; Muratori M; Forti G; Baldi E
    J Cancer Res Clin Oncol; 2004 Oct; 130(10):604-14. PubMed ID: 15258753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
    J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
    Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
    J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eupatilin inhibits EGF-induced JB6 cell transformation by targeting PI3K.
    Li F; Tao Y; Qiao Y; Li K; Jiang Y; Cao C; Ren S; Chang X; Wang X; Wang Y; Xie Y; Dong Z; Zhao J; Liu K
    Int J Oncol; 2016 Sep; 49(3):1148-54. PubMed ID: 27573489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines.
    Razzini G; Berrie CP; Vignati S; Broggini M; Mascetta G; Brancaccio A; Falasca M
    FASEB J; 2000 Jun; 14(9):1179-87. PubMed ID: 10834940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
    Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
    Sun J; Mohlin S; Lundby A; Kazi JU; Hellman U; Påhlman S; Olsen JV; Rönnstrand L
    Oncogene; 2014 Nov; 33(46):5360-9. PubMed ID: 24213578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway.
    Deng Q; Yu X; Xiao L; Hu Z; Luo X; Tao Y; Yang L; Liu X; Chen H; Ding Z; Feng T; Tang Y; Weng X; Gao J; Yi W; Bode AM; Dong Z; Liu J; Cao Y
    Cell Death Dis; 2013 Sep; 4(9):e804. PubMed ID: 24052072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.
    Henken FE; Banerjee NS; Snijders PJ; Meijer CJ; De-Castro Arce J; Rösl F; Broker TR; Chow LT; Steenbergen RD
    Mol Cancer; 2011 Jun; 10():71. PubMed ID: 21663621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB.
    Maag D; Maxwell MJ; Hardesty DA; Boucher KL; Choudhari N; Hanno AG; Ma JF; Snowman AS; Pietropaoli JW; Xu R; Storm PB; Saiardi A; Snyder SH; Resnick AC
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1391-6. PubMed ID: 21220345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.
    Piplani H; Rana C; Vaish V; Vaiphei K; Sanyal SN
    Biochim Biophys Acta; 2013 Nov; 1830(11):5142-56. PubMed ID: 23872169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.
    Takeuchi K; Ito F
    J Biol Chem; 2004 Jan; 279(2):892-900. PubMed ID: 14570904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.